The risk of developing symptoms of depression remains high up to a year after you’ve recovered.In this CME article, explore the mental health consequences associated with the COVID-19 pandemic as well as the potential role for complementary and alternative approaches.Background The COVID-19 pandemic that has resulted in social distancing, lockdowns, and increase in media posts has taken a toll on the mental health of many people especially those living with Generalized Anxiety Disorder (GAD). The main objective of this study is to understand whether the source of information people use to receive information about COVID-19 and increase or decrease in personal weekly habits during the pandemic were associated with severity of GAD. Methods This study was a cross sectional design and was based on data from Canada. The Canadian Perspective Survey Series (CPSS) 4, 2020: Information Sourced Consulted During the Pandemic was used for the study. The outcome variable was severity of GAD. Multivariate logistic regression was carried out using STATA IC 13. Results Severity of GAD was significantly associated with being a female, the type of information source used to find out about COVID-19 and change in weekly habits (consuming alcohol, consuming cannabis spending time on the internet and eating junk foods or sweets). Conclusion The results indicate that getting information from credible sources about the pandemic, staying connected with family and friends, seeking virtual mental health services, and learning positive coping strategies can help reduce the severity of GAD.

Psychologists and psychiatrists have sometimes struggled to keep up with the multiplying mental health challenges posed by the pandemic and other recent events, but through studies and interventions, Vanderbilt faculty members are providing new insights into the crisis—as well as the best evidence-based solutions for overcoming it.The immune-inflammatory response during the acute phase of COVID-19, as assessed using peak body temperature (PBT) and peripheral oxygen saturation (SpO2), predicts the severity of chronic fatigue, depression and anxiety symptoms 3–4 months later. The present study was performed to examine the effects of SpO2 and PBT during acute infection on immune, oxidative and nitrosative stress (IO&NS) pathways and neuropsychiatric symptoms of Long COVID. This study assayed SpO2 and PBT during acute COVID-19, and C-reactive protein (CRP), malondialdehyde (MDA), protein carbonyls (PCs), myeloperoxidase (MPO), nitric oxide (NO), zinc, and glutathione peroxidase (Gpx) in 120 Long COVID individuals and 36 controls. Cluster analysis showed that 31.7% of the Long COVID patients had severe abnormalities in SpO2, body temperature, increased oxidative toxicity (OSTOX) and lowered antioxidant defenses (ANTIOX), and increased total Hamilton Depression (HAMD) and Anxiety (HAMA) and Fibromylagia-Fatigue (FF) scores. Around 60% of the variance in the neuropsychiatric symptoms of Long COVID (a factor extracted from HAMD, HAMA and FF scores) was explained by OSTOX/ANTIOX ratio, PBT and SpO2. Increased PBT predicted increased CRP and lowered ANTIOX and zinc levels, while lowered SpO2 predicted lowered Gpx and increased NO production. Lowered SpO2 strongly predicts OSTOX/ANTIOX during Long COVID. In conclusion, the impact of acute COVID-19 on the symptoms of Long COVID is partly mediated by OSTOX/ANTIOX, especially lowered Gpx and zinc, increased MPO and NO production and lipid peroxidation-associated aldehyde formation. The results suggest that post-viral somatic and mental symptoms have a neuroimmune and neuro-oxidative origin.Implants that track and optimize our brain activity are on the way.

Social isolation and the brain in the pandemic era

Danilo Bzdok and Robin I. M. Dunbar review the neurobiology of human and primate social behaviours and how the pandemic may have disrupted these systems.Review on mindfulness mediation interventions. Patients with mental health symptoms from long COVID receive multispecialty care at the UCHealth Post-COVID Clinic.Experts say yes—but not for the reasons you might expect.

So you’ve had COVID-19? Here’s what to watch for – and what you can do – when it comes to heart and brain health.“This is not a tsunami of new dementia cases,” a Covid researcher said, but added, “A 1.2% increase in the population in absolute terms and compared to in other previous infections is hard to ignore.”. COVID-19 has left some feeling slow, confused or clouded with “brain fog”. Our expert shares how long you can expect it to last, and what you can do to help.This pandemic has created an increased urgency to strengthen mental health systems
in most countries. Mitigation strategies could incorporate ways to promote mental
wellbeing and target determinants of poor mental health and interventions to treat
those with a mental disorder. Taking no action to address the burden of major depressive
disorder and anxiety disorders should not be an option.

While physical effects are widely known, mental health has been overlooked; OHSU Long COVID-19 Program unique in offering counseling and peer support.Self-reporting COVID-19 was longitudinally associated with deterioration in mental
health and life satisfaction. Our findings emphasise the need for greater post-infection
mental health service provision, given the substantial prevalence of COVID-19 in the
UK and worldwide.Some patients with serious reactions to the virus reported mental health symptoms almost a year and a half after infection. Emerging COVID-19 variants, like the Omicron subvariant BA.5 that has recently caused a surge in cases, may pose new risks to children and create challenges for the back-to-school season. Children .

Fatigue, headache among top lingering symptoms months after COVID

The results support the growing evidence that there are chronic neuropsychiatric symptoms following COVID-19 infections.Clinicians and researchers offer advice on how to tell the difference, and what to do about both.How artificial intelligence detects lowered mood, why depression is linked to heart-disease risk, and other highlights. How artificial intelligence detects lowered mood, why depression is linked to heart-disease risk, and other highlights.The COVID-19 Mental Disorders Collaborators conclude that, throughout 2020, the pandemic
led to a 27·6% increase in cases of major depressive disorders and 25·6% increase
in cases of anxiety disorders globally.1 However, we propose that these prevalence
estimates are likely to be substantially inflated. Decades of trauma research has
shown that, for most people, negative life events such as bereavement or disaster
exposure are typically followed by resilience (minimal effect on symptoms of anxiety,
or depression, or both) or recovery (initial short-term increase in symptoms of anxiety,
or depression, or both, followed by recovery).Despite growing awareness that children and teenagers can get depressed, substantial gaps remain in diagnosis and treatment. Despite growing awareness that children and teenagers can get depressed, substantial gaps remain in diagnosis and treatment.Jennifer Christian Herman, Ph.D., vice president, Mindbody Medicine at Blue Shield of California, shares important points for seniors about behavioral health, mental health stigma, the pandemic’s effect on this health issue, and how treatment and self-care can help.

Tackling mental health disorders among survivors of covid-19 should be a priority, say researchers A study published by The BMJ today finds that covid-19 is associated with an increased risk of mental health disorders, including anxiety, depression, substance use, and sleep disorders, up to one year after initial infection. The findings suggest that tackling mental. We are in the third year of the COVID-19 pandemic, and across the world, most restrictions have lifted, and society is trying to get back to “normal.” But for many people—potentially millions globa. New Study: At Least 30% of Those Infected Suffered from ‘Long COVID’ New research has found that 30 percent of people treated for COVID-19 developed lingering symptoms, commonly known as “long COVID.” According to the study from the University of California Los Angeles (UCLA), published in Springer, patients with a history of hospitalization from COVID, and those with diabetes and higher body mass index (BMI) were most likely to develop long COVID. “Surprisingly, ethnicity, older age, and socioeconomic status were not associated with the syndrome — even though those characteristics have been linked with severe illness and greater risk of death from COVID-19,” states a news release by UCLA. Among the 309 people with long COVID that were part of the study, the most persistent symptoms were fatigue and shortness of breath (31 percent and 15 percent, respectively) in hospitalized persons, and loss of sense of smell (16 percent) in outpatients. Overall, UCLA researchers reviewed data on 1,038 people who were enrolled in the UCLA COVID Ambulatory Program between April 2020 and February 2021. Of those, 309 developed long COVID. A study participant was determined to suffer from long COVID if they reported persistent symptoms on questionnaires 60 or 90 days after infection or hospitalization, UCLA researchers said. “This study illustrates the need to follow diverse patient populations longitudinally to understand the Long COVID disease trajectory and evaluate how individual factors such as pre-existing co-morbidities, sociodemographic factors, vaccination status and virus variant type affect type and persistence of Long COVID symptoms,” said Sun Yoo, M.D., health sciences assistant clinical professor at David Geffen School of Medicine at UCLA and medical director of the Extensivist Program. Dr. Yoo added that improvements in diagnosing long COVID are needed to “differentiate it from exacerbations of other emerging or chronic conditions” and “ensure equitable access to outpatient Long COVID care.” Researchers: Even 1.25 Hours of Brisk Walking Weekly Can Lower Risk of Depression Even short bouts of physical activity, such as brisk walking, could significantly lower the risk of depression, according to a new analysis of previous studies on the benefits of regular exercise. The so-called meta-analysis, published in the journal JAMA Psychiatry, focused on 15 studies involving more than 190,000 individuals to see how much exercise was needed to reduce depression, a serious mental health issue that is common and can negatively affect daily living. For overall health, the U.S. guidelines for physical activity for adults include: at least 150 minutes (2.5 hours) per week of moderate-intensity aerobic activity (such as brisk walking); or 75 minutes per week of vigorous aerobic activity, or a combination of both, preferably spread throughout the week. However, in the case of preventing depression, the levels of physical activity did not need to meet the established guidelines to be effective. The new analysis found that adults who were involved in activities equivalent to 1.25 hours of brisk walking per week had an 18 percent lower risk of depression, compared with those who did not exercise. “Activity volume equivalent to 2.5 hours of brisk walking per week (the minimum recommended under U.S. guidelines) was associated with 25 percent lower risk of depression,” the study’s authors said. Only minor additional benefits were observed at higher activity levels, the researchers said. The study concluded: “This systematic review and meta-analysis of associations between physical activity and depression suggests significant mental health benefits from being physically active, even at levels below the public health recommendations. Health practitioners should therefore encourage any increase in physical activity to improve mental health.” Pfizer-BioNTech Plan to Seek Approval for COVID Booster for Kids 5-11 Pfizer-BioNTech plans to submit a request for emergency ese authorization of a booster dose for children ages 5 to 11 after the companies reported that a third dose significantly raised antibody levels in kids within that age group as part of a clinical trial. The trial of the booster shot included 140 children ages 5 through 11. In 30 kids, Pfizer said. After analyzing antibody levels in a subset of 30 children, researchers measured a 36-fold increase in antibodies against the Omicron variant. The children received a booster dose approximately 6 months after the second dose of the Pfizer-BioNTech COVID-19 vaccine. There was no evidence of prior COVID-19 infection in all 140 study participants. The companies said there were no safety issues associated with a booster dose in these small groups of children. A primary series of two 10-µg doses of the Pfizer-BioNTech vaccine was previously authorized by U.S. regulators for this age group in October 2021. Booster doses of Pfizer-BioNTech’s Covid-19 vaccine are already authorized for those age 12 and older.

The pandemic’s true toll on mental health won’t be known for a long time, but data from the past two years indicates a rise — some of it sharp — in prescription drugs for conditions like A.D.H.D. and depression.A Columbia expert explains how to recognize the signs of seasonal affective disorder and why it’s important to treat it as the COVID outbreak continues.A Denver resident opens up about his experience with ketamine therapy after a life of treatment-resistant depression and anxiety.Knowing what to say and do to support a loved one with depression can be a challenge. These tips can provide guidance.The COVID-19 pandemic is impacting mental health, with some populations bearing a greater burden. In this cross-sectional online study, we examined the personal and intersectional factors associated with increased symptoms of anxiety and depression following the COVID-19 pandemic. We assessed pre- and post-pandemic levels of anxiety and depressive symptoms using the Generalized Anxiety Disorder-2 (GAD-2) and Patient Health Questionnaire-9 (PHQ-9) scales, respectively. The study included 1847 participants, with an age range of 18 to 79 years and representing 43 countries. Variables with significance (p < 0.05) in predicting post-pandemic GAD-2 and PHQ-9 scores were pre-pandemic scores on the same scales, an interaction between increasing age and non-man gender, and an interaction between non-man gender and having children. Health practitioners, psychiatrists, and policy makers need to be aware and respond to the mental health burden of the pandemic on women and other gendered individuals, especially those who care for children.“I’ve finally got the excitement back”: Some long Covid patients, aided by specialized clinics, are seeing their symptoms get better as they strive for full recovery.